END STAGE LUNG FAILURE. I. End stage lung disease, causing chronic respiratory failure, as confirmed and evidenced by all of the following: i. FEV1 test results consistently less than 1 litre measured on 3 occasions 3 months apart; and ii. Requiring continuous permanent supplementary oxygen therapy for hypoxemia; and iii. Arterial blood gas analysis with partial oxygen pressures of 55mmHg or less (PaO2 <55 mm Hg); and iv. Dyspnea at rest.
Appears in 2 contracts
END STAGE LUNG FAILURE. I. End stage lung disease, causing chronic respiratory failure, as confirmed and evidenced by all of the following:the
i. FEV1 test results consistently less than 1 litre measured on 3 occasions 3 months apart; and
ii. Requiring continuous permanent supplementary oxygen therapy for hypoxemia; and
iii. Arterial blood gas analysis with partial oxygen pressures of 55mmHg or less (PaO2 <55 mm Hg); and
iv. Dyspnea at rest.
Appears in 2 contracts
END STAGE LUNG FAILURE. I. End stage lung disease, causing chronic respiratory failure, as confirmed and evidenced by all of the following:
i. FEV1 test results consistently less than 1 litre measured on 3 occasions 3 months apart; and
ii. Requiring continuous permanent supplementary oxygen therapy for hypoxemia; and
iii. Arterial blood gas analysis with partial oxygen pressures pressure of 55mmHg or less (PaO2 <55 mm Hg< 55mmHg); and
iv. Dyspnea at rest.
Appears in 2 contracts
Samples: Insurance Agreement, Insurance Agreement
